Ovaries Could Hold the Key to Longevity

For most of modern medicine, the ovaries were understood as reproductive organs. That framing is being challenged.

Early in 2026, the XPRIZE Foundation announced a $50 million prize focused on women’s health, with ovarian preservation as one of its central targets. The reasoning goes well beyond fertility. Ovarian hormones, including estrogen and progesterone, regulate bone density, cardiovascular function, brain health, and metabolic balance. When ovarian function declines sharply at menopause, all of these systems become vulnerable simultaneously. Researchers now argue this is not a coincidence.

TIME and National Geographic covered the growing scientific movement in depth. In animal studies, older female mice that received young ovarian transplants lived longer and showed improved physical function. Direct application to humans remains far off, but the mechanistic research connecting ovarian aging to whole-body aging is advancing quickly.

Three approaches are currently drawing the most attention from researchers: pharmacological interventions to extend ovarian function, tracking ovarian aging biomarkers such as AMH (anti-Müllerian hormone), and identifying lifestyle factors that slow ovarian decline.

What This Means

A long-underfunded area of women’s health is finally receiving serious resources and scientific attention. Reframing ovarian health from a reproductive concern to a longevity and whole-body health concern opens new possibilities for earlier intervention. For women in their 30s and 40s, this research could eventually inform proactive strategies that go well beyond conventional reproductive medicine.